The oral GLP-1 market is driven by the rising prevalence of type 2 diabetes and obesity, increasing demand for convenient oral treatments, and growing awareness of effective diabetes management options
Qian ZY, Peng Q, Zhang ZW, Zhou LA, Miao Y
This study also tracked the function of inflammation, apoptosis, oxidative stress, and nitrosative stress in mediating the effects of our treatment regimens
Like many employers, they wanted to know: What is the real impact of GLP-1s on diabetes? Specifically, they want to understand whether the investment in GLP-1s has been effective in a) helping their diabetic population of nearly 3,000 employees and members better manage their chronic disease and b) addressing the $40M+ in annual spend for this population
41 Understanding the gut-brain axis in the context of DAN opens new avenues for therapeutic interventions
These dysfunctions contribute to the development of depression